PATENT CLAIM ANALYSIS

Application Number: 15860894
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-05
Patent Classification: ["514", "210210"]

Abstract:
Provided herein are compounds of the Formula I: or pharmaceutically acceptable salt or solvate thereof, wherein A, B, X 1 , X 2 , X 3 , X 4 , Ring D, E, R a , R b , n and m have the meanings given in the specification, which are inhibitors of RET kinase and are useful in the treatment and prevention of diseases which can be treated with a RET kinase inhibitor, including RET-associated diseases and disorders.

Claim (Index 27):
The method of  claim 1 , further comprising administering an additional therapy or therapeutic agent to the patient.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 86.0
- Lexical Diversity: 1.6
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15861244', '15860808', '15860852', '15858929', '15858240']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8272884380627455
- 35 USC 102 Novelty (BERT): 0.6162083336568946
- Combined Prediction Score: 0.8061804276221605
- Mean Citation Score: 599.3505399999998
- Max Citation Score: 612.18823
- Similarity Product: 483.554933548401

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test